BMY vs OFG · P/E 17, rev $24.46B vs P/E 9.6, rev $391.3M
Bristol-Myers Squibb Company (BMY) versus OFG Bancorp (OFG) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
OFG Bancorp (OFG) is a banks - regional company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported OFG revenue for 2026-06-30 was $391.3M. Net income was $112.7M. OFG currently screens at market cap $1.97B and trailing P/E 9.6.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. OFG currently screens at market cap $1.97B and trailing P/E 9.6.
Not investment advice. Open the BMY and OFG stock pages for the full models.
Not investment advice.